Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.
about
How to select the best available related or unrelated donor of hematopoietic stem cells?What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant ImmunogeneticsPredicting alloreactivity in transplantation.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysisRisk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.Blood and marrow transplant clinical trials network state of the Science Symposium 2014A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.A perspective on the selection of unrelated donors and cord blood units for transplantationEffect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCTRole of HLA in Hematopoietic Stem Cell Transplantation.Genetics of graft-versus-host disease: the major histocompatibility complex.Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.On the future of HLA.HLA DNA typing: past, present, and future.Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications.Role of non-HLA gene polymorphisms in graft-versus-host disease.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.In celebration of Ruggero Ceppellini: HLA in transplantation.Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation.Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.Predicting relevant immunogenetic disparities.Allogeneic stem cell transplantation for acute myeloid leukemia.Identification of a novel HLA-DPB1 allele, HLA-DPB1*167:01, in a Chinese individual.In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors.Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin.Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice.Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.HLA-typing analysis following allogeneic bone grafting for sinus lifting.Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation.Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.
P2860
Q26744109-C73DA053-5DB1-49BF-8A64-2FDCCF5A2296Q28075219-51E2E3D0-50E2-4A2C-BFE8-B50B7E119FCEQ33608371-2D8AE8C5-2C60-461B-BC86-DFF74EAE43BEQ33642419-1BD22BD6-0E5C-48BC-9E5A-E19367B7444BQ33689153-FF3E3E39-4A7D-42D3-920B-702A72E1AF3BQ34135396-9A0A9A80-2406-485C-911E-74F4C18F5CC8Q34353744-657EAA8B-6FBD-44FA-BE70-BBFE503C6EFFQ34749292-74D02533-54FD-463A-A6C3-F6ECD238A93CQ34768153-F8E8E448-1AA7-471D-9D58-2C81EA8DF6E9Q35591760-92938B72-B97F-4BB6-8625-C3835E317C87Q36091059-E7148BCE-F0F3-4E97-AFAD-64EA9703DDEAQ36100445-EBD359AC-47CF-47D6-BB7F-763E926A9FCDQ36305321-AE40698F-6185-4C95-BD29-61976774322EQ36307305-7A5A5769-9B3C-40EF-90F2-3EB527B33C85Q36766250-BE127862-224F-4BFC-94C1-B74C04A1F5A4Q37268004-BE3F6550-2971-4F84-85D0-02B744B6A747Q37935058-7BFD36E2-4547-42A3-BABC-F14011AD149FQ38014961-CA54C951-563F-4013-B2DA-7E3FF8263BEBQ38062303-4A9FCF45-0EE7-43D8-8A90-7202265DE346Q38104375-EC5E3711-7BBE-48E0-92D5-4CA959A7D1CDQ38129337-1D049DC0-32CD-414F-9CFA-FFF61D679784Q38922475-F4D8F3B3-7F19-4628-9EE0-72A369E1A356Q39094693-54E827BA-4418-45ED-8079-1C82D0716830Q39123538-66214191-CE42-4136-A384-F6ED01DE9DCCQ39544554-40EE265E-B85A-4A7B-AF89-C66D4DEFA219Q40343240-0C6E3628-2E9E-4C50-88C9-78F409AEBE28Q42428458-9547C2C2-608F-4A4C-A709-955FA40D3292Q42765065-E7CE8E03-4690-40C0-8B0F-8498C95AAE6FQ44188886-77089CC9-B2C1-492F-9FFE-DB91DEB955FFQ44571503-ECB0FCD3-56AD-4EA4-9802-46848972F9A3Q46609060-48351DD9-B877-4742-ACD6-73D652B89503Q47587797-4A8E51F9-2292-482B-B50B-FF173205908BQ47615845-5200D0B7-1D89-4DC6-BB28-9333F48A3677Q47795034-4B5685F5-5F9F-475B-8359-8113264306A0Q48162670-F602B3D6-4AFA-45A9-9254-283DFDBA66C4Q50868968-021F5A10-4ABD-46E6-8163-03BD535FD056Q51017262-EE8A8C72-D46D-453F-B225-FE7BDDF6AC24Q51362313-892EE34C-73C0-44A0-BD49-41A8241DA221Q52620753-57B2039C-27FA-472A-BE94-9C2DAB492870Q52766742-FC9E12BE-B5DA-4B80-97AF-D7F3197B7B7E
P2860
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@en
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@nl
type
label
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@en
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@nl
prefLabel
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@en
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@nl
P2093
P1433
P1476
Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.
@en
P2093
Alberto Bosi
Andrea Bacigalupo
Barbara Bruno
Elisabetta Zino
Fabio Ciceri
Giuseppe Bandini
Gruppo Italiano Trapianto di M ...... iche (CSE) e Terapia Cellulare
Italian Bone Marrow Donor Registry
Jessica Marcon
Katharina Fleischhauer
P304
P356
10.1182/BLOOD-2009-01-200378
P407
P577
2009-06-10T00:00:00Z